zopiclone has been researched along with Liver Diseases in 2 studies
zopiclone: S(+)-enantiomer of racemic zopiclone; azabicyclo(4.3.0)nonane; a nonbenzodiazepine; one of the so-called of Z drugs (zopiclone, eszopiclone, zolpidem, and zaleplon) for which there is some correlation with tumors; was term of zopiclone 2004-2007
zopiclone : A pyrrolo[3,4-b]pyrazine compound having a 4-methylpiperazine-1-carboxyl group at the 5-position, a 5-chloropyridin-2-yl group at the 6-position and an oxo-substituent at the 7-position.
Liver Diseases: Pathological processes of the LIVER.
Excerpt | Relevance | Reference |
---|---|---|
" The carrier of hypnotic activity is the parent compound; however, knowledge of its metabolic profile is essential for the understanding of pharmacokinetic changes in various pathophysiological conditions." | 1.27 | Critical factors for pharmacokinetics of zopiclone in the elderly and in patients with liver and renal insufficiency. ( Dreyfus, JF; Gaillot, J; Houghton, GW; Le Roux, Y, 1987) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Parker, G | 1 |
Roberts, CJ | 1 |
Gaillot, J | 1 |
Le Roux, Y | 1 |
Houghton, GW | 1 |
Dreyfus, JF | 1 |
2 other studies available for zopiclone and Liver Diseases
Article | Year |
---|---|
Plasma concentrations and central nervous system effects of the new hypnotic agent zopiclone in patients with chronic liver disease.
Topics: Adult; Aged; Azabicyclo Compounds; Central Nervous System Depressants; Chronic Disease; Electroencep | 1983 |
Critical factors for pharmacokinetics of zopiclone in the elderly and in patients with liver and renal insufficiency.
Topics: Adult; Age Factors; Aged; Animals; Azabicyclo Compounds; Biological Availability; Dogs; Half-Life; H | 1987 |